Brief: Histogen And Amerimmune Announce Presentation Of Emricasan Data In COVID-19 At The American College Of Allergy, Asthma, And Immunology Conference
Nov 2 (Reuters) - Histogen Inc HSTO.O :
* HISTOGEN AND AMERIMMUNE ANNOUNCE THE PRESENTATION OF
EMRICASAN
DATA IN COVID-19 AT THE AMERICAN COLLEGE OF ALLERGY, ASTHMA, AND
IMMUNOLOGY CONFERENCE
Source text for Eikon: ID:nGNXcgFnzl
Further company coverage: HSTO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Histogen
See all newsBrief: Histogen Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Histogen Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Histogen Announces Board Approval Of Complete Liquidation And Dissolution
Histogen Inc expected to post a loss of 90 cents a share - Earnings Preview
Histogen to explore strategic options, shares up